CARGO Therapeutics, Inc. Common Stock
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $96,710,000.
Profit Margin
| 2021 | 0 | -5.85M | |
|---|---|---|---|
| 2022 | 0 | -40.95M | |
| 2023 | 0 | -98.14M |
CRGX Income Statement (2021 – 2023)
| 2023 | 2022 | 2021 | |
|---|---|---|---|
Revenue | |||
Revenue | 0 | 0 | 0 |
Cost of revenue | 3.69M | 0 | 0 |
Gross profit | -3.69M | 0 | 0 |
Operating exp. | |||
Research and development | 75.79M | 29.37M | 4.46M |
Selling and marketing | -3.69M | 0 | 0 |
Total operating expenses | 96.71M | 34.77M | 5.97M |
Operating income | -96.71M | -34.77M | -5.97M |
Other income (expenses), net | -1.43M | -1.23M | 127K |
Income before tax | -98.14M | -40.95M | -5.85M |
Income tax expense | 0 | 4.92M | 127K |
Net income | -98.14M | -40.95M | -5.85M |
Earnings per share | |||
Basic EPS | -2.38 | -2.13 | -0.3 |
Diluted EPS | -2.38 | -2.13 | -0.3 |
| Data source |